Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis

Table 5 Comparison of demographic data between patients remaining compensated and individuals progressing to decompensation during the follow-up period

	Patients remaining compensated (n = 107)	Patients progressing to decompensation (n = 43)	P value
Male [n (%)]	66 (61.7)	22 (51.2)	NS1
Female [n (%)]	41 (38.3)	21 (48.8)	NS1
Age (mean ± SD)	61.81 ± 10.99	66.47 ± 12.01	NS2
Child-Pugh Grade A [n (%)]	78 (72.9)	29 (67.5)	NS1
Child-Pugh Grade B [n (%)]	29 (27.1)	14 (32.5)	NS1

¹Chi-square test.

²Mann-Whitney U test.

Statistically significant differences (P < 0.05) are reported in bold. NS: Not statistically significant.